Connor, Clark & Lunn Investment Management Ltd. - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 172 filers reported holding NOVAVAX INC in Q4 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of NOVAVAX INC
ValueSharesWeighting
Q3 2018$292,000
+430.9%
155,553
+276.6%
0.00%
Q2 2018$55,000
-91.8%
41,300
-48.9%
0.00%
-100.0%
Q1 2015$669,000
+173.1%
80,900
+95.9%
0.01%
+200.0%
Q4 2014$245,000
-85.1%
41,300
-87.4%
0.00%
-83.3%
Q1 2014$1,644,000328,8350.01%
Other shareholders
NOVAVAX INC shareholders Q4 2018
NameSharesValueWeighting ↓
Parametrica Management Ltd 61,882$438,0002.76%
BB BIOTECH AG 8,330,000$58,893,0001.87%
Cormorant Asset Management, LP 1,600,000$11,312,0001.81%
HARVEY CAPITAL MANAGEMENT INC 623,950$4,411,0001.76%
WILLIAM HARRIS INVESTORS INC 488,666$3,455,0000.98%
Eventide Asset Management 2,097,500$14,829,0000.86%
AWM Investment Company, Inc. 400,000$2,828,0000.55%
NORTHPOINTE CAPITAL LLC 507,344$3,587,0000.47%
Rock Springs Capital Management LP 715,000$5,055,0000.41%
Opus Point Partners Management, LLC 100,000$707,0000.39%
View complete list of NOVAVAX INC shareholders